High-molecular weight adiponectin/HOMA-IR ratio as a biomarker of metabolic syndrome in urban multiethnic Brazilian subjects

Blood-Based Biomarkers for Metabolic Syndrome

(2016) Sadhbh O’Neill et al.   TRENDS IN ENDOCRINOLOGY AND METABOLISM

Circulating Endocannabinoids and the Polymorphism 385C>A in Fatty Acid Amide Hydrolase (FAAH) Gene May Identify the Obesity Phenotype Related to Cardiometabolic Risk: A Study Conducted in a Brazilian Population of Complex Interethnic Admixture

(2015) Cyro José de Moraes Martins et al.   PLoS One

Hypoadiponectinemia Is Strongly Associated with Metabolic Syndrome in Korean Type 2 Diabetes Patients

(2013) Han Kyoung Ryu et al.   JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION

Revisiting the Genetic Ancestry of Brazilians Using Autosomal AIM-Indels

(2013) Fernanda Saloum de Neves Manta et al.   PLoS One

Metabolic Syndrome and Risk of Cancer: A systematic review and meta-analysis

(2012) K. Esposito et al.   DIABETES CARE

Adiponectin: mechanistic insights and clinical implications

(2012) A. T. Turer et al.   DIABETOLOGIA

Race–ethnic differences in adipokine levels: the Study of Women's Health Across the Nation (SWAN)

(2012) Unab I. Khan et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

The Ratio of Adiponectin to HOMA as an Index of Metabolic Syndrome in Obese Women

(2011) Daniel Antonio de Luis et al.   ANNALS OF NUTRITION AND METABOLISM

Evaluating the Clinical Utility of a Biomarker

(2011) Mark J. Pletcher et al.   CIRCULATION

The ratio of adiponectin to homeostasis model assessment of insulin resistance is a powerful index of each component of metabolic syndrome in an aged Japanese population: Results from the KING Study

(2011) Masahiro Nakatochi et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Harmonizing the Metabolic Syndrome

(2009) K.G.M.M. Alberti et al.   CIRCULATION

High-molecular-weight adiponectin is a predictor of progression to metabolic syndrome: a population-based 6-year follow-up study in Japanese men

(2009) Yoshie Seino et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Metabolic syndrome—what is the clinical usefulness?

(2008) Richard Kahn   LANCET